Literature DB >> 16635010

Results of thyroidectomy in 101 cats with hyperthyroidism.

Elaine C Naan1, Jolle Kirpensteijn, Hans S Kooistra, Marijke E Peeters.   

Abstract

OBJECTIVE: To describe outcome after thyroidectomy in hyperthyroid cats, with emphasis on peri- and postsurgical complications and recurrence. STUDY
DESIGN: Retrospective study. ANIMALS: One hundred and one hyperthyroid cats.
METHODS: Diagnostic work-up included preoperative measurement of plasma calcium, sodium, potassium, urea, and creatinine concentrations, and thyroid scintigraphy. A modified intracapsular dissection technique was performed. Postoperatively, parathyroid gland function was evaluated by measuring plasma calcium concentration several times daily. Outcome was obtained by standard telephone questionnaire.
RESULTS: Thyroid scintigraphy revealed ectopic hyperplastic thyroid tissue (EHTT) in 9 cats. Preoperatively, 29 of 91 cats had hypokalemia. Two cats died within 3 days after surgery and 5 of 86 cats developed postoperative transient hypocalcemia. On histologic examination, thyroid carcinoma was identified in 3 of 88 cats. Hyperthyroidism recurred in 5 cats between 3 and 59 months; 4 of these cats had EHTT preoperatively. The difference in recurrence rate between hyperthyroid cats with and without EHTT was significant (P<.001).
CONCLUSION: Complications were uncommon after thyroidectomy performed by an experienced surgeon when combined with an anesthetic regimen associated with minimal adverse cardiovascular effects. Hyperthyroid cats with EHTT had a significantly higher chance of recurrence. CLINICAL RELEVANCE: Thyroidectomy is associated with a low incidence of surgical complications and is an effective treatment for hyperthyroid cats when radioactive iodine therapy is not available. Preoperative thyroid scintigraphy is advised. Surgery is not recommended when EHTT is present, because of a higher chance of developing recurrent disease.

Entities:  

Mesh:

Year:  2006        PMID: 16635010     DOI: 10.1111/j.1532-950X.2006.00146.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  8 in total

1.  The outcome for feline non-hypersecretory thyroid carcinoma after thyroidectomy.

Authors:  Alberto Oramas; Sarah Boston; Vincent Wavreille
Journal:  Can Vet J       Date:  2020-07       Impact factor: 1.008

2.  Bilateral thyroid follicular compact-cellular carcinoma in a llama.

Authors:  Rodrigo A Carrasco; Jolanda Verhoef; Carlos E P Leonardi; Emily E Lanigan; Gregg P Adams
Journal:  J Vet Diagn Invest       Date:  2019-10-24       Impact factor: 1.279

3.  Efficacy of Low-dose (2 millicurie) versus Standard-dose (4 millicurie) Radioiodine Treatment for Cats with Mild-to-Moderate Hyperthyroidism.

Authors:  J M Lucy; M E Peterson; J F Randolph; P V Scrivani; M Rishniw; D L Davignon; M S Thompson; J M Scarlett
Journal:  J Vet Intern Med       Date:  2017-02-03       Impact factor: 3.333

4.  Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease.

Authors:  D H N van den Broek; R F Geddes; T L Williams; Y-M Chang; J Elliott; R E Jepson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

Review 5.  Imaging in Non-neurologic Oncologic Treatment Planning of the Head and Neck.

Authors:  Katherine S Hansen; Michael S Kent
Journal:  Front Vet Sci       Date:  2019-03-28

6.  Expected total thyroxine (TT4) concentrations and outlier values in 531,765 cats in the United States (2014-2015).

Authors:  Maya Lottati; David Aucoin; David S Bruyette
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

7.  Changes in thyroid and renal function after bilateral thyroidectomy in cats.

Authors:  Heather L Covey; Yu-Mei Chang; Jonathan Elliott; Harriet M Syme
Journal:  J Vet Intern Med       Date:  2019-02-13       Impact factor: 3.333

Review 8.  Hyperthyroid cats and their kidneys: a literature review.

Authors:  L Yu; L Lacorcia; T Johnstone
Journal:  Aust Vet J       Date:  2022-06-16       Impact factor: 1.343

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.